Human cells involved in atherosclerosis have a sex

Flavia Franconi1, Giuseppe Rosano2, Stefania Basili3

  • 1Assessorato alle Politiche per la Persona of Basilicata Region, Potenza, Italy; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Insights

Sex significantly influences cardiovascular diseases like atherosclerosis. This review highlights sex differences in cells and processes, revealing knowledge gaps and the need for including both sexes in research.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Sex influences cardiovascular diseases, yet cellular sex differences in atherosclerosis are understudied.
  • Atherosclerosis involves diverse cells (vascular, immune, endothelial progenitor), with limited reporting on cellular sex.
  • Sex hormones play a crucial role in atherosclerotic processes.

Purpose of the Study:

  • To review sex differences in human cells involved in atherosclerosis.
  • To emphasize the role of sex hormones in atherosclerotic cell behavior.
  • To explore sex-based variations in cellular fate mechanisms like apoptosis and autophagy.

Main Methods:

  • Literature review focusing on sex differences in cellular mechanisms of atherosclerosis.
  • Analysis of studies reporting sex-specific data on vascular cells, immune cells, and endothelial progenitor cells.
  • Examination of sex hormone influences and sex differences in apoptotic and autophagic pathways.

Main Results:

  • Significant knowledge gaps exist regarding sex influences on many cell types in atherosclerosis.
  • Sex differences are observed in cellular processes, including apoptosis and autophagy.
  • Current research often fails to report the sex of cells or include both sexes in preclinical studies.

Conclusions:

  • There is a critical need to define experimental conditions clearly and include both sexes in preclinical atherosclerosis studies.
  • Understanding sex differences at the cellular level is essential for advancing atherosclerosis research.
  • Further investigation into sex-specific cellular mechanisms is required to address knowledge gaps.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Inflammation01:38

Inflammation

Overview
63.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
860
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
677